Cargando…

A clinical trial investigating biodistribution and shedding of an oncolytic virus

Detalles Bibliográficos
Autores principales:	Reale, Alberto, Calistri, Arianna, Palù, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796555/ https://www.ncbi.nlm.nih.gov/pubmed/31420301 http://dx.doi.org/10.1016/j.ebiom.2019.08.011

Ejemplares similares

Perspectives on immunotherapy via oncolytic viruses
por: Reale, Alberto, et al.
Publicado: (2019)

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
por: Reale, Alberto, et al.
Publicado: (2021)

Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanoma
por: Andtbacka, Robert H.I., et al.
Publicado: (2019)

Why Cells and Viruses Cannot Survive without an ESCRT
por: Calistri, Arianna, et al.
Publicado: (2021)

Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer
por: Reale, Alberto, et al.
Publicado: (2023)

Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs
por: Béguin, Jérémy, et al.
Publicado: (2021)

What goes in the regulatory clinical pharmacology package for an oncolytic virus?
por: Yum, Sun Young, et al.
Publicado: (2023)

Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment
por: Onnockx, Sheela, et al.
Publicado: (2023)

The chaos law is a principal driver of natural selection: A proposition on the evolution of recently emerged coronaviruses
por: Roggero, Pier Francesco, et al.
Publicado: (2023)

On the intrinsic nature of viral pathogenesis: The assumption of a Darwinian paradigm to describe COVID-19 pandemic
por: Roggero, Pier Francesco, et al.
Publicado: (2022)

Ebola Virus Entry: From Molecular Characterization to Drug Discovery
por: Salata, Cristiano, et al.
Publicado: (2019)

Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages
por: Sartori, Elena, et al.
Publicado: (2011)

Oncolytic immunotherapy: multiple mechanisms of oncolytic peptides to confer anticancer immunity
por: Tang, Tianyu, et al.
Publicado: (2022)

Recommendations for Regulating the Environmental Risk of Shedding for Gene Therapy and Oncolytic Viruses in Canada
por: Bubela, Tania, et al.
Publicado: (2019)

Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles
por: Autio, Karoliina, et al.
Publicado: (2014)

In Vivo Safety, Biodistribution and Antitumor Effects of uPAR Retargeted Oncolytic Measles Virus in Syngeneic Cancer Models
por: Jing, Yuqi, et al.
Publicado: (2014)

Efficacy of Systemically Administered Retargeted Oncolytic Herpes Simplex Viruses—Clearance and Biodistribution in Naïve and HSV-Preimmune Mice
por: Vannini, Andrea, et al.
Publicado: (2023)

View and review on viral oncology research
por: Bergonzini, Valeria, et al.
Publicado: (2010)

The Ubiquitin-Conjugating System: Multiple Roles in Viral Replication and Infection
por: Calistri, Arianna, et al.
Publicado: (2014)

Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine
por: Engeland, Christine E.
Publicado: (2022)

Shedding Light on Adaptation
por: Hurley, James B.
Publicado: (2002)

Shedding Light On Cones
por: Knox, Barry E., et al.
Publicado: (2006)

Clinical Trials of Oncolytic Viruses in Breast Cancer
por: Carter, Mary E., et al.
Publicado: (2021)

Two roads for oncolytic immunotherapy development
por: Kaufman, Howard L., et al.
Publicado: (2019)

Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy
por: Gómez, Ana, et al.
Publicado: (2020)

Toxicology and Biodistribution Studies for MGH2.1, an Oncolytic Virus that Expresses Two Prodrug-activating Genes, in Combination with Prodrugs
por: Kasai, Kazue, et al.
Publicado: (2013)

Oncolytic virotherapy targeting the IL15 pathway
por: Yoo, So Young, et al.
Publicado: (2023)

PTEN potentiation of oncolytic HSV therapy for glioblastoma
por: Migliarese, Christian, et al.
Publicado: (2023)

The Herpes Simplex Virus-1 genome contains multiple clusters of repeated G-quadruplex: Implications for the antiviral activity of a G-quadruplex ligand
por: Artusi, Sara, et al.
Publicado: (2015)

Plasmonics sheds light on the nanotechnology of daguerreotypes
por: Halas, Naomi J.
Publicado: (2019)

The worm sheds light on anesthetic mechanisms
por: Singaram, Vinod K., et al.
Publicado: (2012)

Report of two cases of influenza virus A/H1N1v and B co-infection during the 2010/2011 epidemics in the Italian Veneto Region
por: Calistri, Arianna, et al.
Publicado: (2011)

Toxicology and Biodistribution: The Clinical Value of Animal Biodistribution Studies
por: Silva Lima, Beatriz, et al.
Publicado: (2018)

Pandemic influenza A (H1N1v) infection in pediatric population: a multicenter study in a North-East area of Italy
por: Da Dalt, Liviana, et al.
Publicado: (2011)

Oncolytic virotherapy meets the human organoid technology for pancreatic cancers
por: Fiorini, Elena, et al.
Publicado: (2020)

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses
por: Ungerechts, Guy, et al.
Publicado: (2016)

Shedding new light on genetic dark matter
por: Melhem, Nadine, et al.
Publicado: (2010)

Shedding metabo‘light’ on the search for sepsis biomarkers
por: dos Santos, Claudia C.
Publicado: (2015)

Natural killers shed attachments to kill again
por: Felce, James H., et al.
Publicado: (2018)

Oncolytic viruses and checkpoint inhibitors: combination therapy in clinical trials
por: LaRocca, Christopher J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9mv8a77gfirc52ub06jldq0v13